Literature DB >> 20830735

Identification of p10 as a neurotoxic product generated from the proteolytic cleavage of the neuronal Cdk5 activator.

Jenny Chew1, Minghui Jessica Chen, Alan Yiu-Wah Lee, Zhao Feng Peng, Kevin Wai Yin Chong, Lisheng He, Boon Huat Bay, Jian Ming Jeremy Ng, Robert Z Qi, Nam Sang Cheung.   

Abstract

The involvement of cyclin-dependent kinase-5 (Cdk5) and p25, the proteolytic fragment of activator p35, has long been implicated in the development of neuron-fibrillary tangles (NFTs), a hallmark of Alzheimer's disease (AD). Findings in this area over the past decade have been highly controversial and inconclusive. Here we report unprecedented detection of endogenous p10, the smaller proteolytic fragment of the Cdk5 activator p35 in treated primary cortical neurons that underwent significant apoptosis, triggered by proteasome inhibitors MG132 and lactacystin, and protein kinase inhibitor staurosporine (STS). p10 appeared exclusively in the detergent-resistant fraction made up of nuclear matrix, membrane-bound organelles, insoluble membrane proteins, and cytoskeletal components. Intriguingly, transient overexpression of p10 in neural cells induced apoptotic morphologies, suggesting that p10 may play an important role in mediating neuronal cell death in neurodegenerative diseases. We demonstrated for the first time that p10-mediated apoptosis occurred via a caspases-independent pathway. Furthermore, as p10 may contain the myristoylation signal for p35 which is responsible for binding p35 to several intracellular components and the membrane, all in all these novel results present that the accumulation of p10 to the detergent-insoluble fraction may be a crucial pathological event to triggering neuronal cell death.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830735     DOI: 10.1002/jcb.22864

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.

Authors:  Lingyan Zhang; Wen Liu; Karen K Szumlinski; John Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

2.  The interaction of Munc 18 (p67) with the p10 domain of p35 protects in vivo Cdk5/p35 activity from inhibition by TFP5, a peptide derived from p35.

Authors:  Niranjana D Amin; Yali Zheng; Binukumar Bk; Varsha Shukla; Susan Skuntz; Philip Grant; Joseph Steiner; Manju Bhaskar; Harish C Pant
Journal:  Mol Biol Cell       Date:  2016-09-14       Impact factor: 4.138

3.  Cdk5 Inhibitory Peptide Prevents Loss of Dopaminergic Neurons and Alleviates Behavioral Changes in an MPTP Induced Parkinson's Disease Mouse Model.

Authors:  Rongni He; Wei Huang; Yaowei Huang; Miaojing Xu; Pingping Song; Yinwei Huang; Huifang Xie; Yafang Hu
Journal:  Front Aging Neurosci       Date:  2018-06-01       Impact factor: 5.750

Review 4.  Post-translational modifications of CDK5 and their biological roles in cancer.

Authors:  Gui-Bin Gao; Yue Sun; Run-Dong Fang; Ying Wang; Yang Wang; Qing-Yu He
Journal:  Mol Biomed       Date:  2021-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.